| LH/Mav |
systolic blood pressure |
perindopril (1.5 mg/kg/d) (for 42 days) |
Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. |
arterial blood pressure trait |
male |
63.0 days
| 7 |
undefined |
|
113.0 |
mmHg |
3.0 |
7.94 |
tail cuff plethysmography |
|
0.0 |
|
102850 |
2761 |
| LH/Mav |
systolic blood pressure |
vehicle control condition |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
arterial blood pressure trait |
male |
112.0 days
| 11 |
mean of 3 samples of undefined duration |
serial mean |
160.0 |
mmHg |
4.0 |
13.27 |
tail cuff plethysmography |
|
0.0 |
|
102728 |
2721 |
| LH/Mav |
systolic blood pressure |
control condition (between 147 and 154 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
arterial blood pressure trait |
male |
84.0 days
| 12 |
between 9a-1p |
|
152.0 |
mmHg |
3.0 |
10.39 |
tail cuff plethysmography |
|
0.0 |
|
103432 |
2825 |
| LH/Mav |
systolic blood pressure |
controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
arterial blood pressure trait |
male |
84.0 days
| 13 |
between 9a-1p |
|
122.0 |
mmHg |
2.0 |
7.21 |
tail cuff plethysmography |
|
0.0 |
|
103434 |
2825 |
| LH/Mav |
systolic blood pressure |
controlled losartan content drinking water (10 mg/kg/d) (for 63 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
arterial blood pressure trait |
male |
147.0 days-154.0 days |
5 |
2hr mean (10a-12p) |
continuous mean |
166.0 |
mmHg |
3.0 |
6.71 |
vascular fluid filled catheter |
|
0.0 |
|
103437 |
2825 |
| LH/Mav |
systolic blood pressure |
vehicle control condition |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
arterial blood pressure trait |
male |
56.0 days
| 11 |
mean of 3 samples of undefined duration |
serial mean |
134.0 |
mmHg |
4.0 |
13.27 |
tail cuff plethysmography |
|
0.0 |
|
102704 |
2721 |
| LH/Mav |
systolic blood pressure |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
arterial blood pressure trait |
male |
56.0 days
| 14 |
mean of 3 samples of undefined duration |
serial mean |
148.0 |
mmHg |
4.0 |
14.97 |
tail cuff plethysmography |
|
0.0 |
|
102705 |
2721 |
| LH/Mav |
systolic blood pressure |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
arterial blood pressure trait |
male |
49.0 days-56.0 days |
37 |
undefined |
|
145.0 |
mmHg |
2.0 |
12.17 |
tail cuff plethysmography |
|
0.0 |
|
102646 |
2703 |
| LH/Mav |
systolic blood pressure |
control condition |
Dubay C, et al., Nat Genet 1993 Apr;3(4):354-7 |
arterial blood pressure trait |
male |
203.0 days-217.0 days |
16 |
|
serial mean |
174.1 |
mmHg |
|
|
vascular indwelling catheter method |
abdominal aorta |
10800 |
|
11645 |
111 |
| LH/Mav |
systolic blood pressure |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
arterial blood pressure trait |
male |
112.0 days
| 8 |
undefined |
|
169.0 |
mmHg |
5.0 |
14.14 |
tail cuff plethysmography |
|
0.0 |
|
102808 |
2723 |
| LH/Mav |
systolic blood pressure |
nifedipine (50 mg/kg/d) (for 42 days) |
Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. |
arterial blood pressure trait |
male |
63.0 days
| 7 |
undefined |
|
144.0 |
mmHg |
4.0 |
10.58 |
tail cuff plethysmography |
|
0.0 |
|
102851 |
2761 |
| LH/Mav |
systolic blood pressure |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
arterial blood pressure trait |
male |
84.0 days
| 5 |
|
|
161.0 |
mmHg |
6.0 |
13.42 |
tail cuff plethysmography |
|
0.0 |
|
103473 |
2826 |
| LH/Mav |
systolic blood pressure |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
arterial blood pressure trait |
male |
112.0 days
| 4 |
undefined |
|
157.0 |
mmHg |
7.0 |
14.0 |
tail cuff plethysmography |
|
0.0 |
|
102809 |
2723 |
| LH/Mav |
systolic blood pressure |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
arterial blood pressure trait |
male |
112.0 days
| 14 |
mean of 3 samples of undefined duration |
serial mean |
179.0 |
mmHg |
4.0 |
14.97 |
tail cuff plethysmography |
|
0.0 |
|
102729 |
2721 |
| LH/Mav |
systolic blood pressure |
vehicle control condition |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
arterial blood pressure trait |
male |
49.0 days-56.0 days |
8 |
undefined |
|
136.0 |
mmHg |
3.0 |
8.49 |
tail cuff plethysmography |
|
0.0 |
|
102645 |
2703 |
| LH/Mav |
systolic blood pressure |
vehicle control condition |
Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. |
arterial blood pressure trait |
male |
84.0 days
| 8 |
undefined |
|
160.0 |
mmHg |
|
|
tail cuff plethysmography |
|
0.0 |
|
102849 |
2761 |
| LH/Mav |
systolic blood pressure |
vehicle control condition |
Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. |
arterial blood pressure trait |
male |
63.0 days
| 8 |
undefined |
|
160.0 |
mmHg |
3.0 |
8.49 |
tail cuff plethysmography |
|
0.0 |
|
102848 |
2761 |
| LH/Mav |
systolic blood pressure |
hydralazine (75 mg/kg/d) (for 42 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 42 days) and reserpine (0.75 mg/kg/d) (for 42 days) |
Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. |
arterial blood pressure trait |
male |
63.0 days
| 10 |
undefined |
|
133.0 |
mmHg |
2.0 |
6.32 |
tail cuff plethysmography |
|
0.0 |
|
102852 |
2761 |
| LH/Mav |
systolic blood pressure |
controlled perindopril content drinking water (3 mg/kg/d) (for 63 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
arterial blood pressure trait |
male |
84.0 days
| 12 |
between 9a-1p |
|
97.0 |
mmHg |
3.0 |
10.39 |
tail cuff plethysmography |
|
0.0 |
|
103435 |
2825 |
| LH/Mav |
systolic blood pressure |
controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
arterial blood pressure trait |
male |
147.0 days-154.0 days |
6 |
2hr mean (10a-12p) |
continuous mean |
167.0 |
mmHg |
2.0 |
4.9 |
vascular fluid filled catheter |
|
0.0 |
|
103438 |
2825 |
| LH/Mav |
systolic blood pressure |
controlled perindopril content drinking water (3 mg/kg/d) (for 63 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
arterial blood pressure trait |
male |
147.0 days-154.0 days |
6 |
2hr mean (10a-12p) |
continuous mean |
186.0 |
mmHg |
8.0 |
19.6 |
vascular fluid filled catheter |
|
0.0 |
|
103439 |
2825 |
| LH/Mav |
systolic blood pressure |
controlled losartan content drinking water (10 mg/kg/d) (for 63 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
arterial blood pressure trait |
male |
84.0 days
| 13 |
between 9a-1p |
|
129.0 |
mmHg |
2.0 |
7.21 |
tail cuff plethysmography |
|
0.0 |
|
103433 |
2825 |
| LH/Mav |
systolic blood pressure |
control condition (between 147 and 154 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
arterial blood pressure trait |
male |
147.0 days-154.0 days |
6 |
2hr mean (10a-12p) |
continuous mean |
175.0 |
mmHg |
1.0 |
2.45 |
vascular fluid filled catheter |
|
0.0 |
|
103436 |
2825 |